Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
March-2019 Volume 10 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2019 Volume 10 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Case Report Open Access

Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature

  • Authors:
    • Xuesheng Li
    • Jing Wang
    • Hongbo Li
    • Ming Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Prosthodontics, Hainan Stomatological Hospital, Haikou, Hainan 570105, P.R. China, Department of Stomatology, Hainan Branch of Chinese People's Liberation Army General Hospital, Sanya, Hainan 572013, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 352-356
    |
    Published online on: December 18, 2018
       https://doi.org/10.3892/mco.2018.1793
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Kimura's disease (KD) is a rare condition, with only a few cases reported to date, mainly in Asian patients. We herein present the case of a 48‑year‑old man with KD who presented with recurrent masses in the right parotid gland and neck region over a 15‑year period. The masses were not accompanied by pain, or significant functional or neurosensory dysfunction. The results of the laboratory tests revealed an increased eosinophil count and markedly elevated serum IgE levels. On magnetic resonance imaging examination, a widespread abnormal signal was detected in the area of the lesions; the contrast‑enhanced scan revealed inhomogeneous enhancement, with partial involvement of the sternocleidomastoid muscle and the parotid gland. The patient underwent surgical resection of the right parotid and neck masses, and the postoperative pathological examination revealed eosinophilic hyperplastic lymphogranuloma, also referred to as KD. This presented case and review of the relevant literature aim to improve our understanding of KD in order to increase the accuracy of diagnosis, reduce the misdiagnosis rate and ensure proper treatment of this rare disease.

Introduction

Kimura's disease (KD) was first reported in China by Kim in 1937 as eosinophilic hyperplastic lymphogranuloma (1). Until 1948, the disease was widely recognized in Japan and systematically described by Professor Kimura as ‘unusual granulations combined with hyperplastic changes in lymphoid tissue’ (2,3). KD is a chronic disease and its etiology has not been fully elucidated to date. Patients suffering from this condition mainly present with solitary or multiple painless masses in the maxillofacial and other regions, which often recur after treatment (4,5). Clinically, KD is always accompanied by enlarged regional lymph nodes, eosinophilia and markedly elevated serum IgE levels (2,5). This disease has been most commonly diagnosed in middle-aged individuals in the Far East, for example China and Japan (6–8). Thus far, only 200 cases have been reported worldwide. We herein report a rare case of KD in a 48-year-old man and review the relevant literature to help improve the level of clinicians' knowledge regarding the diagnosis and treatment of this disease.

Case report

A 48-year-old man was admitted to the Hainan Branch of Chinese People's Liberation Army General Hospital (Sanya, China) in December 2017, with recurrent masses in the right parotid gland and neck region for ~15 years. The patient was in good overall condition and had no other complaints, such as pain, swelling, local numbness or xerostomia. There were no reported allergies or other systemic manifestations. The patient had undergone surgical resection of the masses twice (1997 and 2000), but the masses recurred both times after ~6 months. Both postoperative pathological diagnoses were lymphadenitis.

Physical examination revealed maxillofacial asymmetry. Hard, mobile masses were identified in the region of the right parotid gland and neck, arranged longitudinally. On palpation, the borders of the masses were clear, without adhesions to the surrounding tissue; the total size was 15×10×3 cm. Masses were also identified in the left supraclavicular fossa, the right forearm near the wrist joint and the left medial upper arm, sized 5×5×2, 4×3×2 and 4×3×1 cm, respectively (Fig. 1). In addition, multiple enlarged lymph nodes were palpated in the submandibular area and the neck region.

Figure 1.

The patient who presented with painless masses (arrows) in the region of the right parotid gland and neck, the left supraclavicular fossa, the right forearm near the wrist joint and the left medial upper arm.

Reviewing the results of the laboratory tests, with an increased eosinophil percentage (0.55%; normal, 0.01–0.05%), markedly elevated serum IgE levels (27,100 IU/ml; normal, 0–100 IU/ml) and leukocyte count (21.78×109/l; normal, 3.5×109/l), and decreased neutrophil percentage (0.28%; normal, 0.50–0.70%). The results of other investigations, including routine urinalysis, liver and kidney function tests, were within normal limits. Chest radiography was also normal.

Ultrasound examination of the right parotid gland region revealed uneven echogenicity, consistent with a high likelihood of a benign tumor (Fig. 2); a low-echogenicity nodule was identified in the right submaxillary region, which was considered to be a reactive hyperplastic lymph node. On magnetic resonance imaging (MRI) examination, a widespread abnormal signal was detected in the right parotid gland and submaxillary region, and a contrast-enhanced scan revealed inhomogeneous enhancement; the right side of the sternocleidomastoid muscle and the parotid gland were partially involved, with half of the lesions wrapped around the carotid sheath (Fig. 3); multiple enlarged lymph nodes were also identified displaying obvious enhancement.

Figure 2.

Ultrasound of the right parotid gland region showing uneven echogenicity.

Figure 3.

Magnetic resonance imaging examination showing widespread abnormal signal was detected. Administration of contrast material revealed uneven enhancement.

A detailed surgical plan was formulated and, following a full preoperative preparation, the right parotid gland and neck masses were resected under general anesthesia, together with the right superficial parotid lobe (Fig. 4).

Figure 4.

Intraoperative view (left panel) and resected specimens (right panel).

Postoperative pathological examination established the diagnosis of eosinophilic hyperplastic lymphogranuloma, also referred to as KD (Fig. 5), with lesions involving the parotid gland and lymph node tissue.

Figure 5.

Diffuse infiltration of the parotid gland by eosinophil granulocytes and lymphocytes (hematoxylin and eosin staining; magnification, ×40).

The patient was administered 25 mg prednisone twice daily for 2 weeks after the definitive diagnosis. On repeat blood tests, the eosinophil count returned to normal levels, and the masses of the left supraclavicular fossa, right forearm and left medial upper arm notably decreased in size. Therefore, the initial treatment was successful in controlling the disease. Next, the patient will be advised to undergo radiotherapy (total dose, 20–50 Gy; 1.8–2.0 Gy per day, five days a week, over the course of 2–5 weeks).

Discussion

KD is a rare condition, with <300 reported cases to date. Based on these cases, KD is rarely observed in Europe and America (9,10), but frequently occurs in East Asian and Southeast Asian populations (11–14), with China and Japan being the most common. The pathogeny of KD remains unknown. The minimum age reported is 5 years, but it mostly occurs in middle-aged men (15–17). Women only account for a small proportion of the patients, with a male:female ratio of ~3:1 (18). Clinically, KD has a specific predilection for the head, neck (5,10) and limbs, with the lesions most commonly developing in the soft tissue, whereas maxillofacial salivary glands and lymph nodes may also be affected. Patients with KD disease often have a long course, manifesting solitary or multiple soft tissue masses. KD is usually associated with peripheral blood eosinophilia and markedly elevated IgE levels.

The etiology of KD remains unknown (4,5,10,13). It has been confirmed that there is no correlation with tuberculosis, bacterial, fungal or viral infections, poisoning or syphilis (19). Most scholars tend to consider KD as an IgE-mediated type I allergy and inflammatory disease (20), and this hypothesis is supported by the increased eosinophil count and IgE levels in the peripheral blood (21,22). Googe et al reported increased IgE levels in KD patients with renal involvement, which supports the theory that KD is an immune response (23); moreover, clinical application of steroid therapy appears to be effective, further supporting this theory. In recent years, Ohta et al measured Th1/Th2 and Tc1/Tc2 lymphocyte subsets by flow cytometry in KD patients, and interestingly observed that Th2 and Tc1 cell numbers increased significantly in patients with KD compared with the healthy control group; therefore, they reported that Th2 and Tc1 cells appear to play an important role in the pathogenesis of KD (24). Other studies demonstrated that the release of cytokines in patients with KD can increase the permeability of the glomerular basement membrane, causing proteinuria, which may ultimately cause renal damage (25,26). Chim et al considered a clonal T-cell lymphoproliferative disorder as the possible cause of KD; however, this result was from a single case study, and the etiological analysis remains speculative (27).

KD patients are typically men in their 30s and the highest incidence of this disease worldwide is observed in the Asian population. Although Asian and non-Asian patients have certain characteristics in common, it has been reported that non-Asian patients do not generally exhibit involvement of the salivary glands (10); by contrast, in Asian patients KD has a predilection for pre-auricular, parotid and submandibular salivary glands, the neck and the maxillofacial region. The majority of the patients present with firm, painless, single or multiple subcutaneous masses, progressively increasing in size. Mass size may vary greatly, ranging from 1 to 7 cm (28). In addition, multiple regional lymph nodes are involved, manifesting as a single or multiple fused nodules. Although KD mostly involves the maxillofacial region, involvement of other sites has also been reported, including the axilla, trunk, kidney, arm, nerves, orbit, spermatic cord and groin (6,29). In the case presented herein, the patient had a right parotid swelling, along with multiple supraclavicular fossa and arm masses for 15 years. The skin overlying the KD lesions was not inflamed, although mild itching was occasionally reported. With disease progression, skin pigmentation, thickening, local erosion and ulceration may develop, sometimes affecting the whole body in severe cases. Some scholars report that renal involvement is a common systemic manifestation that may affect up to 60% of the patients (5,25,30,31). In addition, the disease may be complicated by asthma, fatigue, fever, allergic rhinitis, atopic dermatitis, urticaria and other allergic symptoms (20). KD is generally benign and self-limited, with a prolonged course. On long-term follow-up, malignant transformation has not been reported. The overall prognosis is good, but recurrence is common.

KD patients almost always have marked eosinophilia and elevated serum IgE levels. Some studies report that blood eosinophil counts are closely associated with the size of the lesion, i.e., the bigger the lesion, the higher the eosinophil count (32,33). Physical examination along with US, CT and MRI may help determine the characteristics, boundaries and blood supply of the mass, as well as the presence of lymph node involvement. On US, the mass may exhibit heterogeneous or homogeneous echogenicity (34), occasionally displaying increased vascularity. On CT scans, the lesions are strongly enhanced, reflecting their vascular nature; lymphadenopathy is reported among the typical findings. On MRI, the lesion exhibits intermediate to high signal intensity on T1-weighted images and hyperintense signals on T2-weighted images (35,36). Therefore, imaging may be a useful way of demonstrating the morphology and extent of the lesion, as well as its association with adjacent structures (8).

There are currently no uniform diagnostic criteria for KD. The following characteristics should raise suspicion of KD: i) Young male, with head and/or neck painless mass; ii) local enlarged lymph nodes; iii) long history; iv) parts of body other than the head and neck displaying multiple painless masses, accompanied by pruritus of the overlying skin; v) increased blood eosinophil count and serum IgE level (a high reference value is needed to make a correct diagnosis); and vi) CT and MRI showing a wide range of lesions and multiple enlarged lymph nodes. Based on these clinical manifestations and blood test results, the diagnosis of KD may be preliminarily considered, but the final diagnosis relies on pathological examination. The histopathological characteristics of KD include follicular hyperplasia, eosinophilic infiltrates and proliferation of postcapillary venules (2,10,12,23).

Clinically, the differential diagnosis of KD may include angiolymphoid hyperplasia with eosinophilia (ALHE), Hodgkin's lymphoma, angioimmunoblastic T-cell lymphoma, Langerhans cell histiocytosis, florid follicular hyperplasia, Castleman's disease, dermatopathic lymphadenopathy, sinonasal eosinophilic angiocentric fibrosis, drug reactions and parasitic infections. In the literature, the most common misdiagnosis is ALHE (10,37); however, patients with ALHE have normal IgE levels and no kidney damage (3,9,38,39).

In conclusion, the prognosis for KD is quite favorable, but may recur frequently in the original location (4), with a recurrence rate of up to 25% (40), posing a major challenge to the physician and patient. A standard treatment for KD has not yet been established. The goal of treatment currently is to maintain appearance and functionality, while preventing recurrence and long-term sequelae, including nephritis and myocarditis.

Although surgery is the most widely used treatment method and it can help reach a definite diagnosis (32,33,35,41,42), other options include radiotherapy, systemic corticosteroids, cytotoxic agents, cyclosporin and pentoxifylline (32,33,42). Oral corticosteroids are usually recommended in cases of symptomatic nephrotic syndrome (26) and, in order to prevent relapse and reduce the long-term side effects of steroid therapy, postoperative radiation therapy may be used (low-dose local irradiation, ~25–30 Gy) (43,44). Reportedly, the recurrence rate appears to be lower if two treatment modalities are combined (41). Recently, anti-IgE therapy has been introduced (45), and the size of lesion and peripheral blood eosinophil count of KD patients were reported to decrease following anti-IgE therapy.

In conclusion, KD is a chronic disorder of unknown etiology. In clinical practice, KD is easily misdiagnosed as other inflammatory lesions or benign tumors of the head and neck, so more thorough diagnostic workup is required. Only through a careful medical history and comprehensive clinical examination, combined with laboratory, imaging and histopathological examinations, can a definitive diagnosis be reached and individualized treatment administered.

Acknowledgements

Not applicable.

Funding

The present study was supported by the Hainan Key Research and Development Program (grant no. ZDYF2016170) and the Clinical Research Support Fund of PLA General Hospital (grant no. 2017FC-WJFWZX-22).

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

The patient provided consent for publication of the case details and associated images.

Availability of data and materials

Not applicable.

Authors' contributions

XL took care of the patient, wrote the medical records and wrote the manuscript. JW and HL collected relevant medical records and assisted with writing. MZ was responsible for surgical treatment and paper revision. All the authors have read and approved the final version of this manuscript.

Competing interests

The authors declare that they have no competing interests to disclose.

References

1 

Kim HT: Eosinophilic hyperplastic lymphogranuloma, comparison with Mikulicz's disease. Chin Med J. 23:6991937.

2 

Kung IT, Gibson JB and Bannatyne PM: Kimura's disease: A clinico-pathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia. Pathology. 16:39–44. 1984. View Article : Google Scholar : PubMed/NCBI

3 

Kimura T and Yoshimura S: Unusual granuloma combined with hyperplastic changes in lymphatic tissues. Trans Soc Path Jpn. 13:179–180. 1948.

4 

Abuel-Haija M and Hurford MT: Kimura disease. Arch Pathol Lab Med. 131:650–651. 2007.PubMed/NCBI

5 

Kuo TT, Shih LY and Chan HL: Kimura's disease. Involvement of regional lymph nodes and distinction from angiolymphoid hyperplasia with eosinophilia. Am J Surg Pathol. 12:843–854. 1988. View Article : Google Scholar : PubMed/NCBI

6 

Takeishi M, Makino Y, Nishioka H, Miyawaki T and Kurihara K: Kimura disease: Diagnostic imaging findings and surgical treatment. J Craniofac Surg. 18:1062–1067. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Iwai H, Nakae K, Ikeda K, Ogura M, Miyamoto M, Omae M, Kaneko T and Yamashita T: Kimura disease: Diagnosis and prognostic factors. Otolaryngol Head Neck Surg. 137:306–311. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Park SW, Kim HJ, Sung KJ, Lee JH and Park IS: Kimura disease: CT and MR imaging findings. AJNR Am J Neuroradiol. 33:784–788. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Iguchi Y, Inoue T, Shimono M, Yamamura T, Shigematsu T and Takahashi S: Kimura's disease and its relation to angiolymphoid hyperplasia with eosinophilia: Report of three cases and review of the literature. J Oral Pathol. 15:132–137. 1986. View Article : Google Scholar : PubMed/NCBI

10 

Chen H, Thompson LD, Aguilera NS and Abbondanzo SL: Kimura disease: A clinicopathologic study of 21 cases. Am J Surg Pathol. 28:505–513. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Gumbs MA, Pai NB, Saraiya RJ, Rubinstein J, Vythilingam L and Choi YJ: Kimura's disease: A case report and literature review. J Surg. 70:190–193. 1999.

12 

Hui PK, Chan JK, Ng CS, Kung IT and Gwi E: Lymphadenopathy of Kimura's disease. Am J Surg Pathol. 13:177–186. 1989. View Article : Google Scholar : PubMed/NCBI

13 

Urabe A, Tsuneyoshi M and Enjoji M: Epithelioid hemangioma versus Kimura's disease. A comparative clinicopathologic study. Am J Surg Pathol. 11:758–766. 1987. View Article : Google Scholar : PubMed/NCBI

14 

Xu X, Fu J, Fang Y and Liang L: Kimura disease in children: A case report and a summary of the literature in Chinese. J Pediatr Hematol Oncol. 33:306–311. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Francis IC, Kappagoda MB, Smith J and Kneale K: Kimura's disease of the orbit. Ophthal Plast Reconstr Surg. 4:235–239. 1988. View Article : Google Scholar : PubMed/NCBI

16 

Seregard S: Angiolymphoid hyperplasia with eosinophilia should not be confused with Kimura's disease. Acta Ophthalmol Scand. 79:91–93. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Takagi K, Harada T and Ishikawa E: Kimura's disease (eosinophilic lymphfolliculoid granuloma). Nihon Rinsho. 51:785–788. 1993.(In Japanese). PubMed/NCBI

18 

Tseng CF, Lin HC, Huang SC and Su CY: Kimura's disease presenting as bilateral parotid masses. Eur Arch Otorhinolaryngol. 262:8–10. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Asadi AK: Angiolymphoid hyperplasia with eosinophilia. Dermatol Online J. 8:102002.PubMed/NCBI

20 

Kimura Y, Pawankar R, Aoki M, Niimi Y and Kawana S: Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES. Clin Exp Allergy. 32:1787–1793. 2002. View Article : Google Scholar : PubMed/NCBI

21 

Oguz KK, Ozturk A and Cila A: Magnetic resonance imaging findings in Kimura's disease. Neuroradiology. 46:855–858. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Choi JA, Lee GK, Kong KY, Hong SH, Suh JS, Ahn JM, Lee YJ, Cho KH, Park JG, Choi JY, et al: Imaging findings of Kimura's disease in the soft tissue of the upper extremity. AJR Am J Roentgenol. 184:193–199. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Googe PB, Harris NL and Mihm MC Jr: Kimura's disease and angiolymphoid hyperplasia with eosinophilia: Two distinct histopathological entities. J Cutan Pathol. 14:263–271. 1987. View Article : Google Scholar : PubMed/NCBI

24 

Ohta N, Fukase S, Suzuki Y, Ito T, Yoshitake H and Aoyagi M: Increase of Th2 and Tc1 cells in patients with Kimura's disease. Auris Nasus Larynx. 38:77–82. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Rajpoot DK, Pahl M and Clark J: Nephrotic syndrome associated with Kimura disease. Pediatr Nephrol. 14:486–488. 2000. View Article : Google Scholar : PubMed/NCBI

26 

Uysal IO, Eryilmaz MA, Salk I and Abasiyanik F: Kimura disease in the parotid gland. J Craniofac Surg. 22:337–338. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Chim CS, Fung A, Shek TW, Liang R, Ho WK and Kwong YL: Analysis of clonality in Kimura's disease. Am J Surg Pathol. 26:1083–1086. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Dik VK, van de Wiel BA and Vasmel WL: Kimura's disease of the parotid glands and multiple cervical lymph nodes. Neth J Med. 68:175–177. 2010.PubMed/NCBI

29 

Gopinathan A and Tan TY: Kimura's disease: Imaging patterns on computed tomography. Clin Radiol. 64:994–999. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Chan TM, Chan PC, Chan KW and Cheng IK: IgM nephropathy in a patient with Kimura's disease. Nephron. 58:489–490. 1991. View Article : Google Scholar : PubMed/NCBI

31 

Akosa AB, Sherif A and Maidment CG: Kimura's disease and membranous nephropathy. Nephron. 58:472–474. 1991. View Article : Google Scholar : PubMed/NCBI

32 

Sun QF, Xu DZ, Pan SH, Ding JG, Xue ZQ, Miao CS, Cao GJ and Jin DJ: Kimura disease: Review of the literature. Intern Med J. 38:668–672. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Sakamoto M, Komura A and Nishimura S: Hematoserological analysis of Kimura's disease for optimal treatment. Otolaryngol Head Neck Surg. 132:159–160. 2005. View Article : Google Scholar : PubMed/NCBI

34 

Ragu R, Eng JY and Azlina AR: Kimura's disease of the parotid: A complete clinical-radiological-pathology report. Med J Malaysia. 69:199–201. 2014.PubMed/NCBI

35 

Som PM and Biller HF: Kimura disease involving parotid gland and cervical nodes: CT and MR findings. J Comput Assist Tomogr. 16:320–322. 1992. View Article : Google Scholar : PubMed/NCBI

36 

Takahashi S, Ueda J, Furukawa T, Tsuda M, Nishimura M, Orita H, Tsujimura T and Araki Y: Kimura disease: CT and MR findings. AJNR Am J Neuroradiol. 17:382–385. 1996.PubMed/NCBI

37 

Buggage RR, Spraul CW, Wojno TH and Grossniklaus HE: Kimura disease of the orbit and ocular adnexa. Surv Ophthalmol. 44:79–91. 1999. View Article : Google Scholar : PubMed/NCBI

38 

Katagiri K, Itami S, Hatano Y, Yamaguchi T and Takayasu S: In vivo expression of IL-4, IL-5, IL-13 and IFN-gamma mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br J Dermatol. 137:972–977. 1997. View Article : Google Scholar : PubMed/NCBI

39 

Kimura T and Yoshimura S: E. I: Unusual granuloma combined with hyperplastic changes in lymphatic tissues. Trans Soc Path Jpn. 37:1791948.

40 

Allen PW, Ramakrishna B and MacCormac LB: The histiocytoid hemangiomas and other controversies. Pathol Annu. 27:51–87. 1992.PubMed/NCBI

41 

Hiwatashi A, Hasuo K, Shiina T, Ohga S, Hishiki Y, Fujii K and Ishitoya J: Kimura's disease with bilateral auricular masses. AJNR Am J Neuroradiol. 20:1976–1978. 1999.PubMed/NCBI

42 

Shetty AK, Beaty MW, McGuirt WF Jr, Woods CR and Givner LB: Kimura's disease: A diagnostic challenge. Pediatrics. 110:e392002. View Article : Google Scholar : PubMed/NCBI

43 

Itami J, Arimizu N, Miyoshi T, Ogata H and Miura K: Radiation therapy in Kimura's disease. Acta Oncol. 28:511–514. 1989. View Article : Google Scholar : PubMed/NCBI

44 

Kim GE, Kim WC, Yang WI, Kim SK, Oh WY, Suh HS, Hahn JS and Park CS: Radiation treatment in patients with recurrent Kimura's disease. Int J Radiat Oncol Biol Phys. 38:607–612. 1997. View Article : Google Scholar : PubMed/NCBI

45 

Nonaka M, Sakitani E and Yoshihara T: Anti-IgE therapy to Kimura's disease: A pilot study. Auris Nasus Larynx. 41:384–388. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li X, Wang J, Li H and Zhang M: Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature. Mol Clin Oncol 10: 352-356, 2019.
APA
Li, X., Wang, J., Li, H., & Zhang, M. (2019). Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature. Molecular and Clinical Oncology, 10, 352-356. https://doi.org/10.3892/mco.2018.1793
MLA
Li, X., Wang, J., Li, H., Zhang, M."Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature". Molecular and Clinical Oncology 10.3 (2019): 352-356.
Chicago
Li, X., Wang, J., Li, H., Zhang, M."Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature". Molecular and Clinical Oncology 10, no. 3 (2019): 352-356. https://doi.org/10.3892/mco.2018.1793
Copy and paste a formatted citation
x
Spandidos Publications style
Li X, Wang J, Li H and Zhang M: Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature. Mol Clin Oncol 10: 352-356, 2019.
APA
Li, X., Wang, J., Li, H., & Zhang, M. (2019). Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature. Molecular and Clinical Oncology, 10, 352-356. https://doi.org/10.3892/mco.2018.1793
MLA
Li, X., Wang, J., Li, H., Zhang, M."Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature". Molecular and Clinical Oncology 10.3 (2019): 352-356.
Chicago
Li, X., Wang, J., Li, H., Zhang, M."Misdiagnosed recurrent multiple Kimura's disease: A case report and review of the literature". Molecular and Clinical Oncology 10, no. 3 (2019): 352-356. https://doi.org/10.3892/mco.2018.1793
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team